These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3198155)

  • 21. 3,16-Bisquaternary ammonium steroid derivatives as neuromuscular blocking agents: synthesis and biological evaluation.
    Hu H; Rao Z; Feng M; Wu Z; Xu J; Chen H; Liu P; Xiao Y; Hong X; Hu X; Ke X
    Steroids; 2015 Apr; 96():103-14. PubMed ID: 25637675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroidal neuromuscular blocking agents.
    Buckett WR
    Adv Drug Res; 1975; 10():53-92. PubMed ID: 816179
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular blocking agents: structural modification of (+)-tubocurarine and (minus)-curarine.
    Marshall IG; Murray JB; Smail GA; Stenlake JB
    J Pharm Pharmacol; 1967 Dec; 19():Suppl:53S-70S. PubMed ID: 4383858
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaesthesia and temperature effect mechanism in neuromuscular blocking by N+ quaternary depolarizing drugs.
    Canepa FG
    Nature; 1965 Sep; 207(5002):1149-52. PubMed ID: 4379848
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of drug-receptor dissociation constants at the mammalian neuromuscular junction in the presence and absence of halothane.
    Waud BE; Cheng MC; Waud DR
    J Pharmacol Exp Ther; 1973 Oct; 187(1):40-6. PubMed ID: 4746332
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neuromuscular, anticholinesterase and pressor effects of quaternary ammonium compounds derived from dicresylphosphate].
    Cheymol G
    Therapie; 1972; 27(3):543-53. PubMed ID: 4655219
    [No Abstract]   [Full Text] [Related]  

  • 27. Some trends in the design of new neuromuscular blocking agents.
    Kharkevich DA
    Ann Ist Super Sanita; 1984; 20(1):21-6. PubMed ID: 6534237
    [No Abstract]   [Full Text] [Related]  

  • 28. The pre-junctional site of action of Enhydrina schistosa venom at the neuromuscular junction.
    Geh SL; Chan KE
    Eur J Pharmacol; 1973 Feb; 21(2):115-20. PubMed ID: 4696097
    [No Abstract]   [Full Text] [Related]  

  • 29. Different modes of potentiation by beta-eudesmol, a main compound from Atractylodes lancea, depending on neuromuscular blocking actions of p-phenylene-polymethylene bis-ammonium derivatives in isolated phrenic nerve-diaphragm muscles of normal and alloxan-diabetic mice.
    Kimura M; Kimura I; Muroi M; Tanaka K; Nojima H; Uwano T
    Jpn J Pharmacol; 1992 Sep; 60(1):19-24. PubMed ID: 1460801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New quaternary bis-ammonium combinations derived from orthophosphoris acid, with curarizing properties].
    Cheymol J; Chabrier P; Cheymol G; Nguyen Thanh T; Savignac P
    C R Acad Hebd Seances Acad Sci D; 1968 Jul; 267(4):448-51. PubMed ID: 4971199
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuromuscular blocking activities of some steroidal mono and bis-quaternary ammonium compounds with special reference to NN'-dimethylconessine.
    Busfield D; Child KJ; Clarke AJ; Davis B; Dodds MG
    Br J Pharmacol Chemother; 1968 Mar; 32(3):609-23. PubMed ID: 4966723
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of the hydrophobicity of monoquaternary ammonium compounds in the mechanism of their curariform action].
    Drozhzhin AP; Ibadova DN
    Farmakol Toksikol; 1975; 38(3):289-94. PubMed ID: 132360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The action of the aminoglycosidic antibiotic gentamicin of the isolated rat diaphragm. Potentiation of the neuromuscular blocking activity of gentamicin during combined application with muscle relaxant agents and magnesium.
    Paradelis AG; Triantaphyllidis C; Fidani V; Logaras G
    Arzneimittelforschung; 1974 Nov; 24(11):1774-9. PubMed ID: 4480048
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmacological actions of polymethylene bistrimethylammonium salts. 1949.
    Paton WD; Zaimis EJ
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):60-79; discussion 51-9. PubMed ID: 9142396
    [No Abstract]   [Full Text] [Related]  

  • 35. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium].
    Danilov AF
    Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 16 beta-pyrrolidinosteroidal derivatives.
    Jindal DP; Piplani P; Fajrak H; Prior C; Marshall IG
    Arzneimittelforschung; 2003; 53(2):73-9. PubMed ID: 12642961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of neuromuscular blocking agents on the pre-and postjunctional receptors at the neuromuscular junction].
    Amaki Y
    Masui; 1985 Sep; 34(9):1185-93. PubMed ID: 3003417
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of verapamil and nifedipine on neuromuscular blocking agents].
    Fukushima K; Aoki T; Ishikawa J
    Masui; 1984 Dec; 33(12):1346-50. PubMed ID: 6530737
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of roxatidine on neuromuscular transmission.
    Bossa R; Chiericozzi M; Galatulas I; Salvatore G; Teli M; Baggio G; Castelli M
    In Vivo; 1995; 9(2):113-5. PubMed ID: 7548786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurarine in man.
    Katz RL; Gissen AJ
    Anesthesiology; 1967; 28(3):564-7. PubMed ID: 4225766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.